|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.394 SEK | -1.50% |
|
+12.89% | +53.91% |
| Apr. 26 | InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 05 | Index Pharmaceuticals Holding AB Announces Board Resignations | CI |
InDex Pharmaceuticals Holding AB (publ) reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported revenue was SEK 0.348 million compared to SEK 9.62 million a year ago. Net loss was SEK 56.3 million compared to SEK 22.8 million a year ago.
Basic loss per share from continuing operations was SEK 0.11 compared to SEK 0.04 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +53.91% | 19.11M | |
| +34.00% | 704B | |
| +25.90% | 577B | |
| -7.75% | 348B | |
| +18.53% | 327B | |
| +4.95% | 288B | |
| +15.26% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -4.89% | 147B |
INDEX PHARMACEUTICALS HOLDING AB 
